What pharmaceutical companies have manufacturing plants in the US?

Pharmaceutical companies with manufacturing plants in the United States are life sciences organizations that operate production facilities to manufacture drugs, biologics, vaccines, and advanced therapies for domestic and global markets. These facilities are regulated by the US Food and Drug Administration (FDA) and must comply with Current Good Manufacturing Practice (cGMP) standards to ensure product quality, safety, and consistency.

Many leading pharmaceutical manufacturers maintain extensive US-based production networks. Examples include Pfizer, Johnson & Johnson, Merck & Co., Eli Lilly, AbbVie, Bristol Myers Squibb, Amgen, Moderna, and Gilead Sciences. These companies operate multiple manufacturing sites across states such as North Carolina, New Jersey, Massachusetts, Indiana, and California, producing a wide range of therapies including oncology drugs, immunology treatments, vaccines, insulin, and sterile injectables.

US pharmaceutical manufacturing plants typically integrate advanced production technologies such as biologics fermentation systems, sterile fill-finish lines, continuous manufacturing platforms, and high-containment production suites. These facilities also incorporate validated quality systems, environmental monitoring, and digital batch record management to ensure compliance with regulatory expectations.

In addition to internal manufacturing, many pharmaceutical companies also collaborate with Contract Development and Manufacturing Organizations (CDMOs) to expand production capacity and support clinical-to-commercial scale operations. These combined manufacturing networks play a critical role in maintaining the US pharmaceutical supply chain, supporting clinical trials, ensuring drug availability, and enabling rapid response during public health emergencies.